Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.518
+0.168 (12.44%)
At close: Mar 27, 2026
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 69.35 million as of March 27, 2026. Its market cap has decreased by -24.81% in one year.
Market Cap
69.35M
Enterprise Value
53.45M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.52
Market Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 69.35M, a decrease of -51.97%. That is a compound annual growth rate of -14.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 69.35M | -20.01% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | 144.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |
| Biosergen AB | 85.01M |
| Magle Chemoswed Holding AB | 81.77M |